Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models

Area of Science:

• Neuroscience
• Stem Cell Biology
• Genetics

Background:

• Neurodegenerative diseases like Alzheimer’s and Parkinson’s are characterized by progressive neuronal loss.
• Key pathological hallmarks include inflammation, mitochondrial dysfunction, calcium dysregulation, and protein aggregation.
• Understanding early molecular events is crucial for developing effective interventions.

Purpose of the Study:

• To review the utility of human induced pluripotent stem cells (iPSCs) in modeling neurodegenerative diseases.
• To explore how iPSC-derived neuronal models can elucidate mechanisms of mitochondrial and calcium dysregulation.
• To highlight the potential of iPSC technology for identifying therapeutic targets.

Main Methods:

• Utilizing human induced pluripotent stem cells (iPSCs) to generate patient-specific neuronal models.
• Employing these iPSC-derived neurons to investigate molecular pathways implicated in neurodegeneration.
• Analyzing mitochondrial function and calcium signaling alterations in disease-relevant contexts.

Main Results:

• iPSC-derived neuronal models recapitulate key features of neurodegenerative diseases, including mitochondrial dysfunction and calcium deregulation.
• These models allow for the study of inherited pathogenic mutations' impact on neuronal survival.
• iPSC technology provides a platform to investigate early pathological events not observable in post-mortem tissues.

Conclusions:

• Human iPSCs are a valuable tool for studying the molecular mechanisms of neurodegenerative diseases.
• iPSC-based models facilitate the investigation of calcium and mitochondrial alterations in Alzheimer’s and Parkinson’s disease.
• This approach holds promise for the discovery of novel therapeutic strategies targeting early disease processes.